CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -56.9% | 17,366 | -32.0% | 0.00% | -50.0% |
| Q2 2023 | $58 | +222.2% | 25,542 | +32.0% | 0.00% | +100.0% |
| Q1 2023 | $18 | +12.5% | 19,354 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.9% | 18,758 | +31.5% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | -75.8% | 14,269 | -27.5% | 0.00% | -75.0% |
| Q3 2021 | $95,000 | -41.7% | 19,688 | +92.9% | 0.01% | 0.0% |
| Q3 2017 | $163,000 | – | 10,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |